ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aaronson, K. D.
Right arrow Articles by Pagani, F. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aaronson, K. D.
Right arrow Articles by Pagani, F. D.
Related Collections
Right arrow Mechanical Circulatory Assistance

Ann Thorac Surg 2003;75:S29-S35
© 2003 The Society of Thoracic Surgeons

Supplement

Patient selection for left ventricular assist device therapy

Keith D. Aaronson, MDa, Himanshu Patel, MDb, Francis D. Pagani, MD, PhDb*

a Division of Cardiology, University of Michigan, Ann Arbor, Michigan, USA
b Section of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan, USA

* Address reprint requests to Dr Pagani, Heart Transplant and Circulatory Assist Program, Section of Cardiac Surgery, 2120 Taubman Center, Box 0348, 1500 East Medical Center Dr, Ann Arbor, MI 48109, USA
e-mail: fpagani{at}umich.edu

Presented at the Heart Failure & Circulatory Support Summit, Cleveland, OH, Aug 22–25, 2002.

Abstract

Patient selection for left ventricular assist device (LVAD) therapy is the most important process in obtaining a successful outcome. Evaluation requires assessing the appropriateness for device implantation based on need and risk of LVAD implant to the patient. Appropriate patients can be selected without the need for invasive hemodynamic measurements and selection can be based on symptoms, appropriateness of medical therapy, and on the need for inotropic therapy. Assessing the risk of LVAD therapy to the patient requires evaluating the degree of organ dysfunction and technical factors. Patients should be offered the option of LVAD therapy if they meet criteria for need, possess the potential for organ recovery, and have appropriate operative risk.




This article has been cited by other articles:


Home page
 Card Surg AdultHome page
S. Aggarwal, F. Cheema, M. C. Oz, and Y. Naka
Long-Term Mechanical Circulatory Support
Card. Surg. Adult, January 1, 2008; 3(2008): 1609 - 1628.
[Full Text]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
S. Lee, Y.-H. Park, S.-H. Lim, Y.-T. Kwak, H. Kim, and B.-C. Chang
Successful Mechanical Circulatory Support as a Bridge to Transplantation
Asian Cardiovasc Thorac Ann, June 1, 2007; 15(3): 243 - 245.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. Butler, C. Geisberg, R. Howser, P. M. Portner, J. G. Rogers, M. C. Deng, and R. N. Pierson III
Relationship between renal function and left ventricular assist device use.
Ann. Thorac. Surg., May 1, 2006; 81(5): 1745 - 1751.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The Society of Thoracic Surgeons.